98%
921
2 minutes
20
Purpose: The 2023 outbreak of extensively drug resistant (XDR) (PA) eye infections was linked to the use of non-preserved, multi-use artificial tears purchased online. The lack of preservatives has been attributed to be the predominant factor in the outbreak. This led us to the current study for which the goal was to determine whether common ophthalmic preservatives could eliminate the outbreak XDRPA and other PA keratitis isolates.
Materials And Methods: Time-kill studies were performed in Mueller-Hinton broth (MHB) and phosphate buffered saine (PBS) on 3 PA strains including the XDRPA outbreak strain. Preservatives assessed were benzalkonium chloride (BAK) 0.04%, 0.01%, and 0.004%, Polyquaterium-1 (Polyquad) (PQ) 0.001%, Sodium Perborate (SP) 0.1%, and EDTA 0.1%. In addition, time-kill assays were performed using preserved and a non-preserved commercially-available artificial tears.
Results: BAK 0.04% and 0.01%, and PQ eliminated all PA isolates in both media after 4 h. BAK 0.004% and SP eliminated all PA strains in PBS at 1 h but did not produce bactericidal 99.9% decreases in MHB over 24 h. EDTA did not produce a bactericidal effect in either media. Artificial tears containing sorbic acid 0.25% and edetate disodium 0.1%, PQ, SP, and PURITE eliminated the PA strains within 24 h.
Conclusions: Several common preservatives were effective in eliminating PA strains including the outbreak strain CDC1270. Preservative efficacy was delayed or inhibited in rich media (MHB) compared to PBS. These results suggest that the 2023 outbreak could have been prevented by using a common preservative in the artificial tears.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/02713683.2025.2553642 | DOI Listing |
Ophthalmol Ther
September 2025
Kentucky Eye Institute, Lexington, KY, USA.
Introduction: Chronic ocular surface pain (COSP) is defined as ocular pain that is perceived to originate from the ocular surface and persists for more than 3 months. Clear epidemiological data on COSP prevalence are lacking.
Methods: In 2025, a total of 100 eye care providers were surveyed, including 50 optometrists and 50 ophthalmologists.
Front Med (Lausanne)
August 2025
Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Dry eye disease (DED) is a chronic inflammatory condition with increasing prevalence. Current treatment strategies, including artificial tears and anti-inflammatory agents, often fail to fully relieve ocular discomfort or meet patients' broader clinical needs. Psychosomatic medicine is grounded in the biopsychosocial model of disease.
View Article and Find Full Text PDFClin Exp Ophthalmol
September 2025
Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, San Diego, California, USA.
Retinopathy of prematurity (ROP) remains a major cause of preventable blindness in premature infants worldwide, with increasing incidence due to advancements in neonatal care. Management of ROP has been revolutionised by anti-vascular endothelial growth factor (anti-VEGF) treatments. Pivotal clinical trials have demonstrated the efficacy of anti-VEGF in the management of Type 1 ROP, while investigation of safety and long-term effects is ongoing.
View Article and Find Full Text PDFCurr Eye Res
September 2025
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Purpose: The 2023 outbreak of extensively drug resistant (XDR) (PA) eye infections was linked to the use of non-preserved, multi-use artificial tears purchased online. The lack of preservatives has been attributed to be the predominant factor in the outbreak. This led us to the current study for which the goal was to determine whether common ophthalmic preservatives could eliminate the outbreak XDRPA and other PA keratitis isolates.
View Article and Find Full Text PDFIn Vivo
August 2025
Nobel Eye Institute, Taipei, Taiwan, R.O.C.;
Background/aim: This study aimed to investigate the association between the perioperative usage of hyaluronic acid (HA)-containing artificial tears and the refractive accuracy of cataract surgery in patients with dry eye disease (DED).
Patients And Methods: In this retrospective cohort study, patients with DED who underwent cataract surgery were categorized based on their use of HA-containing artificial tears. A total of 62 eyes were assigned to the non-HA group and 54 eyes to the HA group.